Skip to main content

Hindson Benjamin J.'s Form 4 filing

10x Genomics, Inc. (TXG) · filed Aug 4, 2021

Accession no.
0001209191-21-049643
Filed
Aug 4, 2021
Trade date
Aug 2, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $7.51M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hindson Benjamin J.CIK 0001786391Director, Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 2, 2021Class A Common StockMOption exerciseAcquired+11,114$1.20+$13,336.858,568Direct
Aug 2, 2021Class A Common StockMOption exerciseAcquired+30,552$5.04+$153,982.0889,120Direct
Aug 2, 2021Class A Common StockSSaleDisposed−5,903$178.25F2−$1,052,209.7583,217Direct
Aug 2, 2021Class A Common StockSSaleDisposed−8,050$179.08F3−$1,441,59475,167Direct
Aug 2, 2021Class A Common StockSSaleDisposed−10,713$180.13F4−$1,929,732.6964,454Direct
Aug 2, 2021Class A Common StockSSaleDisposed−8,800$181.13F5−$1,593,94455,654Direct
Aug 2, 2021Class A Common StockSSaleDisposed−5,200$181.98F6−$946,29650,454Direct
Aug 2, 2021Class A Common StockSSaleDisposed−1,800$183.02F7−$329,43648,654Direct
Aug 2, 2021Class A Common StockSSaleDisposed−800$184.02F8−$147,21647,854Direct
Aug 2, 2021Class A Common StockSSaleDisposed−400$184.95F9−$73,98047,454Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 2, 2021Class A Common StockMOption exerciseDisposed−11,114$0.00$059,968Direct
Aug 2, 2021Class A Common StockMOption exerciseDisposed−30,552$0.00$0144,448Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $177.63 to $178.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $178.63 to $179.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $179.63 to $180.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $180.63 to $181.625. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $181.63 to $182.62. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $182.63 to $183.485. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $183.66 to $184.595. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $184.84 to $184.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Referenced by the price of 1 transaction in Table I.

Remarks

Chief Scientific Officer and President

Read the full filing on SEC EDGAR (opens in a new tab)